Japan, Nov. 4 -- DEXON PHARMACEUTICALS INC has got intellectual property rights for 'CANCER MICROENVIRONMENT IMPROVING AGENT, PROPHYLACTIC OR THERAPEUTIC AGENT FOR ANTITUMOR IMMUNE RESPONSE, AND METHOD FOR IMPROVING CANCER MICROENVIRONMENT.' Other related details are as follows:
Application Number: JP,2024-107076
Category (FI): A61P35/00,A61K35/12,A61K45/00,A61P43/00,105,A61K35/28,C12N5/0775,A61P43/00,121,A61K35/32,A61K35/545,A61P37/02
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 3, 2024
Publication Date: Jan. 16
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
